KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to -$117.0 million.

  • Thermo Fisher Scientific's Gains from Investment Securities fell 20.62% to -$117.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$569.0 million, marking a year-over-year decrease of 36.45%. This contributed to the annual value of -$508.0 million for FY2024, which is 15.89% up from last year.
  • Per Thermo Fisher Scientific's latest filing, its Gains from Investment Securities stood at -$117.0 million for Q3 2025, which was down 85.71% from -$63.0 million recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's Gains from Investment Securities peaked at $21.0 million during Q4 2021, and registered a low of -$254.0 million during Q4 2024.
  • Moreover, its 3-year median value for Gains from Investment Securities was -$117.0 million (2025), whereas its average is -$129.7 million.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Gains from Investment Securities skyrocketed by 121.00% in 2021, and later slumped by 5,450.00% in 2022.
  • Over the past 5 years, Thermo Fisher Scientific's Gains from Investment Securities (Quarterly) stood at $2.0 million in 2021, then plummeted by 5,450.00% to -$107.0 million in 2022, then plummeted by 52.34% to -$163.0 million in 2023, then slumped by 55.83% to -$254.0 million in 2024, then decreased by 20.62% to -$117.0 million in 2025.
  • Its Gains from Investment Securities was -$117.0 million in Q3 2025, compared to -$63.0 million in Q2 2025 and -$135.0 million in Q1 2025.